{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:20Z","timestamp":1791078860771,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>A 77-year-old white male presented to the clinic with two isolated cutaneous tumors on his forehead. A cutaneous biopsy showed a focally folliculotropic CD4<jats:sup>+<\/jats:sup> cutaneous lymphoma. The tumors were irradiated with a complete response, and he was started on oral bexarotene. He experienced localized cutaneous relapse 3 months into treatment. These new tumors now revealed a surprisingly CD8<jats:sup>+<\/jats:sup> cytotoxic phenotype, but with the same clone. A systemic workup was negative. His regimen was switched to romidepsin, and he was treated with local radiation again. Another 3.5 months passed in remission until he developed widespread cutaneous tumors. Positron emission tomography\/computed tomography revealed multifocal systemic disease involving his diaphragm, liver, distal duodenum, proximal jejunum, anterior chest wall including pectoral muscles, and lungs without significant adenopathy. He died a few days later. Given his full clinical and pathological course, he was given the diagnosis of an aggressive primary cutaneous T-cell lymphoma, unspecified.<\/jats:p>","DOI":"10.1097\/dad.0000000000000609","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T12:51:16Z","timestamp":1466167876000},"page":"832-837","source":"Crossref","is-referenced-by-count":4,"title":["Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment"],"prefix":"10.1097","volume":"38","author":[{"given":"William T.","family":"Johnson","sequence":"first","affiliation":[{"name":"Department of Medicine for Lankenau Medical Center, Wynnewood, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Leeman-Neill","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Pittsburgh, Pittsburgh, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonhan","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Grandinetti","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Jedrych","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E.","family":"Craig","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, University of Pittsburgh, Pittsburgh, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","article-title":"Non\u2013Mycosis fungoides cutaneous T-cell lymphomas. Report of the 2011 Society for Hematopathology\/European association for Haematopathology workshop","volume":"139","author":"Quintanilla-Martinez","year":"2013","journal-title":"Am J Clin Pathol."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","article-title":"TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and treatment of Cancer (EORTC)","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathologic entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1034\/j.1600-0560.2002.290804.x","article-title":"Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas","volume":"29","author":"Lu","year":"2002","journal-title":"J Cutan Pathol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaad.2009.02.035","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"62","author":"Gormley","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1309\/NNV4L5G5A0KF1T06","article-title":"CD8+ lymphomatoid papulosis and its differential diagnosis","volume":"125","author":"Margo","year":"2006","journal-title":"Am J Clin Pathol."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.3880088","article-title":"Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study","volume":"13","author":"Haghighi","year":"2000","journal-title":"Mod Pathol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1600-0560.2009.01448.x","article-title":"Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-\/medium-sized pleomorphic T-cell lymphoma or a distinct entity?","volume":"37","author":"Suchak","year":"2010","journal-title":"J Cutan Pathol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1365-2133.2000.03888.x","article-title":"CD8-positive juvenile onset mycosis fungoides: an immunohistochemical and genotypic analysis of six cases","volume":"143","author":"Whittam","year":"2000","journal-title":"Br J Dermatol."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","article-title":"Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-Positive Cytotoxic T-Cell Phenotype","volume":"109","author":"Kummer","year":"1997","journal-title":"J Invest Dermatol."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0303-6987.2006.00548.x","article-title":"CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators","volume":"33","author":"Kempf","year":"2006","journal-title":"J Cutan Pathol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1349-7006.2008.01000.x","article-title":"Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: clinicopathological analysis of 27 patients","volume":"100","author":"Hagiwara","year":"2009","journal-title":"Cancer Sci."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol."},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":"Subcutaneous, blastic natural killer. (NK), NK\/T-cell, other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00015550310005889","article-title":"Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation","volume":"84","author":"Berger","year":"2004","journal-title":"Acta Derm Venereol."},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol."},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cup.12423","article-title":"The clinical features and histopathological patterns of folliculotropic mycosis fungoides in a series of 38 cases","volume":"42","author":"Demirkesen","year":"2015","journal-title":"J Cutan Pathol."},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archdermatol.2010.101","article-title":"Folliculotropic mycosis fungoides: single-center study and systematic review","volume":"146","author":"Lehman","year":"2010","journal-title":"Arch Dermatol."},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archderm.138.2.182","article-title":"Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and S\u00e9zary syndrome","volume":"138","author":"Cerroni","year":"2002","journal-title":"Arch Dermatol."},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaad.2005.06.044","article-title":"Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with S\u00e9zary syndrome","volume":"53","author":"Kreuter","year":"2005","journal-title":"J Am Acad Dermatol."},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2005.02.055","article-title":"Bexarotene treatment of late-stage mycosis fungoides and S\u00e9zary syndrome: development of extracutaneous lymphoma in 6 patients","volume":"52","author":"Bouwhuis","year":"2005","journal-title":"J Am Acad Dermatol."},{"key":"R28-20230908","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jamadermatol.2013.8647","article-title":"Clinical remission of primary aggressive CD8+ cutaneous T-cell lymphoma after pralatrexate infusion","volume":"150","author":"Kerdel","year":"2014","journal-title":"JAMA Dermatol."},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 Blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med."},{"key":"R30-20230908","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/DAD.0b013e31821c35cb","article-title":"Expression patterns of the immunosuppressive proteins PD-1\/CD279 and PD-L1\/CD274 at different stages of cutaneous T-cell lymphoma (CTCL)\/mycosis fungoides (MF)","volume":"34","author":"Kantekure","year":"2012","journal-title":"Am J Dermatopathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201611000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:05:18Z","timestamp":1694145918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201611000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000609","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}